You are here: Home » News-CM » Companies » News
Business Standard

Cipla receives 7 observations for its API manufacturing facility in Virgonangar, Bengaluru

Capital Market 

Cipla announced that the USFDA conducted a routine cGMP inspection at its API manufacturing facility in Virgonangar, Bengaluru, from 15 July 2019 to 19 July 2019.

The inspection ended with 7 observations, none of which were repeat or related to data integrity.

The Company will respond to the agency within the stipulated timeline.

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Sat, July 20 2019. 16:20 IST
RECOMMENDED FOR YOU
RECOMMENDED FOR YOU